通过METTL3介导的CDCA7mRNA的m6A修改促进了COAD进展
Mei Hua1, Xiaolu Zhai1, Ying Chen1
1Department of Oncology, Nantong First People's Hospital and Affiliated Hospital 2 of Nantong University, Nantong 226000, China.
Pathology, research and practice
|July 3, 2024
概括
甲基转移酶类3 (METTL3) 通过增加细胞分裂周期相关蛋白7 (CDCA7) mRNA稳定性,促进结肠腺癌 (COAD) 的进展. 这一发现为COAD治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 结肠腺癌 (COAD) 是一种普遍存在的消化系统恶性瘤,死亡率高.
- N6-甲基氨酸 (m6A) 修饰与瘤进展有关.
- 甲基转移酶类3 (METTL3) 在COAD中的作用需要进一步阐明.
研究的目的:
- 研究METTL3在COAD进展中的作用和机制.
- 探索METTL3,细胞分裂周期相关蛋白7 (CDCA7) 和COAD之间的关系.
主要方法:
- 对于COAD-METTL3/CDCA7相关性的GEPIA数据库分析.
- 在体外测试 (CCK-8,流细胞计,transwell) 细胞活力,循环,亡,迁移和入侵.
- 在蛋白质表达的西方污点;在体内瘤生长的异种移植模型;在METTL3-CDCA7相互作用的MeRIP.
主要成果:
- 在COAD组织和细胞中,METTL3和CDCA7的表达率很高.
- 抑制CDCA7抑制了COAD细胞的增殖,迁移,入侵,糖解,EMT和体内瘤的生长,同时促进了亡.
- 通过m6A甲基化,METTL3增强了CDCA7mRNA的稳定性.
结论:
- METTL3通过调节CDCA7mRNA稳定性来促进COAD细胞恶性瘤.
- METTL3代表了COAD治疗的潜在治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Epigenetic Regulation
31.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K


